Professor Adam Vas, MD, PhD †

Prof. Adam Vas, MD
Prof. Adam Vas, MD

The European Association for Clinical Pharmacology and Therapeutics mourns its Honorary President, Professor Adam Vas, who passed away on July 3rd 2014 at the age of 62 years, after a long illness. The Association has lost a highly distinguished scientist, an advocate of Clinical Pharmacology and a tremendously active EACPT board member.

Adam Vas was born in 1952 in Budapest, Hungary where he trained as a medical doctor at the Semmelweis Medical University. He graduated in 1977 and became a specialist in Internal Medicine and in Clinical Pharmacology, receiving a PhD in 1990 for investigations of liver metabolism. Later he spent several months abroad at the Universities of Bern in Switzerland and Newcastle in the UK, and at the Karolinska Institute in Stockholm. Adam Vas joined the Chemical Works of Gedeon Richter Ltd. Budapest in 1993 as Research Director and was until presently the Senior Research Adviser to the CEO. He became full Professor of Medicine at the Szeged University in 2006 and was Head of the Hypertension Clinic of the St. Emerich Hospital in Budapest.

With great enthusiasm Adam Vas worked hard to promote development of the discipline of clinical pharmacology. He had served for the EACPT since 2003, first as Councillor on the EACPT board, and from 2007-2011 as Treasurer. In 2011 he hosted the successful 10th EACPT congress in Budapest after which he was appointed an Honorary President of the Association. In addition, Adam Vas was the current President of the Hungarian Society for Experimental and Clinical Pharmacology and served on several further scientific boards.

Despite all his merits, Adam Vas remained a modest man, who was always open to giving advice and help. The EACPT loses a warm-hearted and very good friend who will remain in our hearts in grateful remembrance. Our sincere condolences go to his wife Gabriella and to his family.

Prof. Gonzalo Calvo, EACPT Chairman             Prof. Ingolf Cascorbi, EACPT Past Chairman

On behalf of the EACPT Board

Comments:0

Leave a Reply